Institutional Ownership
Reviva Pharmaceutcls Hldgs I
CUSIP 76152G100COMQ1 2026
13D / 13G Filings
40
Schedule 13D/13G on record
Beneficial Filers
17
Distinct reporting persons
Largest Stake
27.2%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
40 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | 683 Capital Management, LLC | 13G/A | 3.0% | 3.49M | SEC |
| 2 | Jan 16, 2026 | Integrated Core Strategies (Us) LLC | 13G/A | 11.0% | 3.26M | SEC |
| 3 | Dec 22, 2025 | Vedanta Partners, LLC | 13D/A | 5.2% | — | SEC |
| 4 | Sep 29, 2025 | 683 Capital Management, LLC | 13G | 5.4% | 5.43M | SEC |
| 5 | Sep 24, 2025 | Vedanta Partners, LLC | 13D/A | 6.2% | — | SEC |
| 6 | Sep 24, 2025 | Bhat Laxminarayan | 13D/A | 3.8% | — | SEC |
| 7 | Aug 14, 2025 | Cvi Investments, Inc. | 13G/A | 4.9% | 3.57M | SEC |
| 8 | Aug 14, 2025 | Tang Capital Management, LLC | 13G/A | 4.8% | 3.40M | SEC |
| 9 | Aug 14, 2025 | Highbridge Capital Management, LLC | 13G | 9.9% | 8.00M | SEC |
| 10 | Jul 1, 2025 | Cvi Investments, Inc. | 13G | 5.9% | 4.00M | SEC |
30 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Reviva Pharmaceutcls Hldgs I.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ifp Advisors, Inc | 4.0K | $714 |